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Abstract
The modification of DNA by methylation is an important epigenetic mechanism that affects the spatial and temporal
regulation of gene expression. Methylation patterns have been described in many contexts within and across a range of
species. However, the extent to which changes in methylation might underlie inter-species differences in gene regulation, in
particular between humans and other primates, has not yet been studied. To this end, we studied DNA methylation
patterns in livers, hearts, and kidneys from multiple humans and chimpanzees, using tissue samples for which genome-wide
gene expression data were also available. Using the multi-species gene expression and methylation data for 7,723 genes, we
were able to study the role of promoter DNA methylation in the evolution of gene regulation across tissues and species. We
found that inter-tissue methylation patterns are often conserved between humans and chimpanzees. However, we also
found a large number of gene expression differences between species that might be explained, at least in part, by
corresponding differences in methylation levels. In particular, we estimate that, in the tissues we studied, inter-species
differences in promoter methylation might underlie as much as 12%–18% of differences in gene expression levels between
humans and chimpanzees.
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Introduction
Changes in the regulation of gene expression levels have long
been hypothesized to play an important role in primate evolution
[1,2]. To begin to address this hypothesis, a large number of
studies have characterized gene expression differences across
primates, in particular between humans and chimpanzees [3–9].
These studies have pointed to several classes of biological processes
(such as transcriptional regulation, oxidative stress response, and a
number of metabolic pathways), which might have evolved under
natural selection in primates. In addition, in a few cases, com-
parative studies in primates have been able to draw strong con-
nections between regulatory adaptations and ultimate physiolog-
ical or anatomical phenotypes [10–15].
Despite the wealth of comparative gene expression data, there
are many fewer studies of the mechanisms that underlie inter-
primate differences in gene regulation (e.g., [12,13,16–18]). In
particular, we know relatively little about the degree to which
changes in epigenetic profiles might explain differences in gene
expression levels between primates.
One of the most extensively studied epigenetic mechanisms
is DNA methylation – an epigenetic modification that facilitates
fine-tuned regulation of transcription rates [19,20]. Spatial and
temporal regulation of transcription by DNA methylation has
been shown to play an important role in many contexts, including
in female X-chromosome inactivation [21,22], genomic imprint-
ing [23,24], and susceptibility to complex diseases in humans,
especially cancers [25,26]. Methylation is also essential for proper
differentiation and development of mammalian tissues [27,28].
For instance, the knockout of genes encoding for the DNA-methyl-
transferase (DNMT) enzymes, which are responsible for de-novo
methylation of DNA, results in embryonic lethality in mice
[29,30].
The causal relationship between changes in promoter DNA
methylation and differences in gene regulation has been well
established [28,31]. It has been shown that hyper-methylation at
promoter CpG islands typically results in decreased transcription
of downstream genes [32]. When methylation is experimentally
removed from promoter regions, transcription levels rise [33]. The
specific mechanisms by which DNA methylation affects gene
regulation are less clear, though DNA methylation is thought to
interact with proteins (such as methyl-DNA binding proteins) that
associate with histone modifications or the nucleosome in order to
maintain a silenced chromatin state [28,31,34,35]. Additionally, it
has been proposed that the bindingof the transcriptional machinery
and enhancer-related transcription factors to methylated genomic
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absolute gene silencing [28,36].
Previous studies have typically described patterns of DNA
methylation in a single or few tissues across species [26,37–41] or
in multiple tissues or developmental stages within a single
organism [26,27,34,42–45]. Comparative studies of DNA meth-
ylation across mammals have suggested that the role of DNA
methylation in tissue-specific gene regulation is generally con-
served. For example, after identifying Tissue-specific Differentially
Methylated Regions (T-DMRs [42]), in heart, colon, kidney, testis,
spleen, and muscle tissues in mice, Kitamura and colleagues were
able to use the methylation status in orthologous human regions to
distinguish between the corresponding human tissues [44]. Irizarry
and colleagues [26], who studied genome-wide DNA methylation
patterns in spleen, liver, and brain tissues from human and mouse,
reported that 51% of T-DMRs are shared across both species.
However, there also are a large number of potentially functional
differences in methylation levels across species. In particular, in
primates, Gama-Sosa and colleagues [39] found that relative
methylation levels within tissues generally differ between species,
with the exception of hyper-methylation in the brain and thymus,
which were observed regardless of species. In addition, Enard and
colleagues [38], who compared methylation profiles of 36 genes in
livers, brains, and lymphocytes from humans and chimpanzees,
reported significant inter-species methylation level differences in
22 of the 36 genes, in at least one tissue.
With few exceptions, however (e.g., [46]), comparative studies in
primates have not explored the extent to which methylation
differences between species might contribute to the genome-wide
regulation of inter-species differences in gene expression levels.
Towards this goal, we compared genome-wide gene expression
levels and DNA methylation data in tissue samples from humans
and chimpanzees.
Results
We characterized DNA promoter methylation across the
genome in samples from heart, liver, and kidney tissues from
both humans and chimpanzees, using two technical replicates
from six individual samples of each tissue from each species (see
Figure S1 for an illustration of the study design). Since genome-
wide gene expression data were previously collected from the same
tissue samples [8], we were able to study the relationships between
DNA methylation and gene expression levels across tissues and
species. The gene-specific expression level estimates and methyl-
ation profiles, for all samples, are provided in Table S1.
DNA methylation varies more across tissues than
between humans and chimpanzees
We obtained methylation profiles from each sample (using two
independent DNA extraction replicates) by using the Illumina
HumanMethylation27 DNA Analysis BeadChip assay, which
provides reproducible (Figure S2) quantitative estimates of
methylation levels at 27,578 CpG-loci near transcription start
sites. Since the 50 bp probes on the Illumina array were designed
to interrogate human samples, we limited our analysis to probes
that were a perfect sequence match to the chimpanzee genome. In
addition, we only used probes that were associated with genes for
which we had expression measurements across the three tissues
[8]. Following these exclusion criteria, we retained 10,575 CpG
site probes in the putative promoter regions of 7,723 genes (see
Methods for more details). At each probe, DNA methylation levels
were estimated using the Illumina-recommended b values, which
are essentially estimates of the proportion of methylated DNA at
each CpG site (see Methods).
We note that limiting our analysis to identical methylation
probes in humans and chimpanzees resulted in a slight (0.5%) but
significant decrease of the median sequence divergence estimates
within 500 bp windows around the retained probes (Figure S3).
As a result, it is possible that, in what follows, we slightly under-
estimate the proportion of inter-species differences in methylation
levels. However, we confirmed that limiting our analysis to
identical methylation probes in the two species did not result in a
noticeable shift in the distribution of expression levels of the
associated genes, nor in the proportion of observed differences in
gene expression levels between the two species.
As a first step of our analysis, we examined patterns of promoter
methylation across tissues and species. As expected [28,31], we
found a negative correlation between methylation and gene
expression levels in each individual, whereby, regardless of tissue
and species, the promoters of highly expressed genes tended to be
lowly methylated while the promoters of lowly expressed genes
were usually highly methylated (Figure 1A; Figure S4). We also
confirmed that methylation patterns on the X-chromosome
account for variation due to sex, regardless of species, as expected
due to X-inactivation in mammalian females [21] (the first
component of variance, corresponding to sex, accounts for 67% of
the overall variation in the X-chromosome data; Figure 1B).
Finally, we found that genes known to be imprinted in humans
tend to show a similar hemi-methylation pattern in chimpanzees
(permutation tests P,0.001; Figure 1C), suggesting that the im-
printed status of this set of genes is conserved in the two species.
For the remainder of the analyses, we considered only the
methylation data from autosomal probes. We observed that
methylation patterns across different tissues and species were quite
distinct (Figure 2; similar patterns for the expression data in Figure
S5). The first component of variance for the autosomal probes,
accounting for 69.3% of the overall variation in methylation,
distinguished samples based on tissue, while the second principal
component (accounting for 12.7% of the overall variation),
separated the species. Overall, an average of 14.5% (range of
8.2–26.1%, depending on the pairwise comparison) of the assayed
promoter CpG sites were differentially methylated between tissues
Author Summary
It has long been hypothesized that changes in gene
regulation have played an important role in primate evo-
lution. However, despite the wealth of comparative gene
expression data, there arestillonlyfew studies thatfocus on
the mechanisms underlying inter-primate differences in
gene regulation. Inparticular, we know relatively littleabout
the degree to which changes in epigenetic profiles might
explain differences in gene expression levels between
primates. To this end, we studied DNA methylation and
gene expression levels in livers, hearts, and kidneys from
multiple humans and chimpanzees. Using these compara-
tive data, we were able to study the evolution of gene
regulation in the context of conservation of or changes in
DNA methylation profiles across tissues and species. We
found that inter-tissue methylation patterns are often
conserved between humans and chimpanzees. In addition,
we also found a large number of gene expression
differences between species, which might be explained, at
least in part, by corresponding differences in methylation
levels. We estimate that, in the tissues we studied, inter-
species differences in methylation levels might underlie as
much as 12%–18% of differences in gene expression levels
between humans and chimpanzees.
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of 3.4–13.5%, depending on the tissue) were differentially
methylated between humans and chimpanzees (at FDR,0.001).
Reassuringly, these patterns recapitulate previous observations in
human and mouse [26,44].
Methylation patterns in T-DMRs are often conserved
We identified regions with tissue-specific patterns of methylation
(T-DMRs [26,42]) by analyzing the data from each species
separately (Figure 3). Specifically, we modeled the methylation
data (namely, the b values) from each autosomal CpG site
independently, using a linear mixed-effects model with a fixed
effect for the tissue and a random effect to account for variation
between individuals. We tested for differences in methylation levels
between tissues by using likelihood ratio tests within the framework
of the linear model (see Methods). Using this approach, we
identified 1,578 and 1,401 T-DMRs in humans and chimpanzees,
respectively (at an FDR,0.001; Figure 3A; Table S1).
Tissue-specific methylation profiles are of interest because they
may underlie tissue-specific patterns of gene expression levels. To
test this hypothesis, we calculated, separately for each species,
Pearson correlation values between promoter methylation profiles
and the corresponding gene expression levels, across the three
tissues. If methylation was consistently used to silence tissue-specific
Figure 1. Genome-wide methylation patterns across all sam-
ples. (A) Probability density functions (y-axis) of estimated promoter
methylation levels (plotted as b-values on the x-axis) for genes whose
Figure 2. Principal components analysis of the methylation
profiles. This analysis only considers the 9,911 autosomal CpG sites
from all samples (PC1 and PC2 are plotted on the x-axis and y-axis,
respectively).
doi:10.1371/journal.pgen.1001316.g002
expression levels are in the lowest (black) and highest (red) quartiles. (B)
Principal components analysis of the methylation data from the 365 X-
chromosome probes from all samples (PC1 is plotted on the y-axis, with
sample indices on the x-axis). (C) Density (y-axes) histograms of b-values
in humans (left) and chimpanzees (right) for 90 CpG-sites associated
with 27 genes previously identified as imprinted in humans. The red
lines indicate the b-value distributions in the genes with evidence for
imprinting, while the grey lines are b-value distributions in ten sets of
90 randomly chosen probes.
doi:10.1371/journal.pgen.1001316.g001
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abundance of negative correlations between the estimates of
methylation and gene expression levels. However, when we
considered the data for all genes that were expressed in at least
one tissue, we found no evidence for an enrichment of negative
correlations between methylation and gene expression levels
(Figure 3B, Figure S6; 48% and 49% of the correlation values
were negative in human and chimpanzee, respectively). In contrast,
when we restricted the analysis to species-specific T-DMRs, we
found an enrichment of negative correlations between methylation
and gene expression levels (Figure 3B; 64% and 67% of correlation
values were negative in human and chimpanzee, respectively;
Fisher’s exact P,10
216). Thisresult suggests that T-DMRsunderlie
a subset of gene expression differences across tissues, a notion that is
consistent with the important role played by DNA methylation in
tissue differentiation in a wide range of species [42].
We then focused on the subset of T-DMRs with the same
methylation pattern in both species. We found that 18–26%
(depending on the tissue) of loci classified as T-DMRs in either
human or chimpanzee are shared between the two species
(Figure 3A, Table S2), a highly significant overlap compared to
that expected by chance alone (hypergeometric distribution P
values across all pairwise tissue comparisons ,10
216). Important-
ly, the observation of a significant overlap in T-DMRs across
species is robust with respect to the statistical cutoff used to classify
T-DMRs (0.001#FDR#0.05; Table S2). Interestingly, when we
considered correlations of methylation and gene expression levels
only at conserved T-DMRs, we found an even more pronounced
enrichment of negative correlations (Figure 3B and 3C; 72% of the
correlation values were negative, regardless of species; Fisher’s
exact for an enrichment of negative correlations: P,10
223),
suggesting that conservation of T-DMRs often relates to
functionally important tissue-specific patterns of gene regulation.
It is perhaps interesting to note that we did not find a difference
in the correlation of methylation and expression levels between T-
DMR CpG sites that are located within or outside an annotated
CpG island (as defined by [47]; Figure S7).
When we examined the functional annotations of genes
associated with species-specific T-DMRs as well as conserved T-
DMRs (using gene ontology annotations), we found an expected
Figure 3. Conservation of tissue-specific differentially methylated regions. (A) Venn diagrams of the number of T-DMRs classified in each
species per tissue. (B) Probability density functions (y-axis) of distributions of Pearson correlations (x-axis) between methylation and gene expression
levels across tissues, in human (solid lines) and chimpanzee (broken lines), for all genes expressed in at least one tissue (black), genes associated with
a T-DMR in only one species (blue), and genes associated with a conserved T-DMRs (red). See Figure S4 for plots of the tissue-specific data (C) A
representative example of a heart-specific T-DMR associated with the CASQ1 gene. Plotted in the left panels are the methylation b-values (y-axis), and
in the right panels are the normalized gene expression levels (y-axis) in liver, kidney, and heart samples from human (top) and chimpanzee (bottom).
doi:10.1371/journal.pgen.1001316.g003
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processes, regardless of tissue (P,5610
23; FDR,0.3; Table S3),
congruent with the importance of epigenetic modification in tissue
differentiation. We also found enrichments of tissue-specific
biological processes, such as genes associated with cardiac muscle
cell differentiation processes among heart T-DMRs (P,5610
23;
FDR,0.3), genes associated with embryonic organ morphogenesis
and embryonic organ development processes among kidney T-
DMRs (P,5610
24; FDR,0.05), and genes associated with blood
coagulation and with the regulation of body fluid levels (putatively
involved in homeostatic functions) among liver T-DMRs (P,10
25;
FDR,6610
23 and P,10
24;F D R ,0.007, respectively). The
enrichment of genes associated with both developmental and
tissue-specific processes among genes associated with T-DMRs is
consistent with previous observations [27,42]. Furthermore, when
we considered only conserved T-DMRs, we observed a significant
under-representation of genes associated with nucleic-acid and
primary metabolic processes in all three tissues studied (all
P,5610
23; FDR,0.01; Table S4). This result suggests that the
epigenetically-mediated tissue-specific regulation of these core
processes tends to be conserved between humans and chimpanzees.
Inter-species differences in methylation
We next focused on the relationships between inter-species
differences in methylation profiles and differences in gene
expression levels between humans and chimpanzees. To estimate
the relative contribution of changes in DNA methylation to inter-
species differences in gene expression levels, we used linear
regression analysis to account for promoter methylation effects
(per autosomal CpG site) before analyzing the gene expression
data from both species. We analyzed methylation and gene
expression data in each tissue using a linear model framework
similar to the one described in Blekhman et al. 2008 [8]. We then
compared the evidence supporting an inter-species difference in
gene expression levels before and after correcting for methylation
profiles (see Methods for more details).
For the majority of genes (78%, 82%, and 77% in liver, kidney,
and heart, respectively; Figure 4A), the evidence for a difference in
expression level between the species was similar, regardless of
whether or not methylation status was taken into account. For a
small subset of genes (1%, 3%, and 2% in liver, kidney, and heart,
respectively), we did not find compelling evidence for a difference
in expression level between the species using the uncorrected
expression level data, but after correcting for methylation levels
using regression analysis, we rejected the null hypothesis of no inter-
species differences in gene expression level (at an FDR,0.01). This
observation,however,isunlikelytobebiologicallymeaningful,since
itisexpectedbychancealone(bypermutationanalysis;P.0.434for
all tissues; Figure S8).
In contrast, in all three tissues, we found a significant
enrichment of genes for which the evidence for inter-species
differences in expression level was compelling (FDR,0.01) before,
but not after we corrected for the methylation levels (21%, 15%,
and 21% in liver, kidney, and heart, respectively, permutation
analysis yields P,0.001 for all tissues; Figure 4B and 4C). Based
on the expectation of such a pattern by chance alone (by
permutations – see Methods for details), we estimated that, in the
three tissues we studied, inter-species differences in promoter DNA
methylation might underlie as much as 12–18% of differences in
gene expression levels between humans and chimpanzees.
When we analyzed the data considering only the sets of genes
that have negative correlations between methylation and gene
expression levels (as expected if methylation is used to silence gene
expression), we found that 8.1%, 7.6%, and 8.8% of interspecies
differences in gene expression levels in liver, kidney, and heart,
respectively, might be explained by corresponding methylation
differences. The extent to which inter-species gene expression
differences might be explained by methylation differences between
the species was similar regardless of whether the methylated site
was within or outside an annotated CpG islands (Figure S9).
Discussion
We explored the extent to which putatively functional DNA
methylation differences between tissues are conserved in humans
and chimpanzees, and estimated the relative contribution of inter-
species changes in methylation levels to gene expression differences
between the two species. To do so, we collected DNA methylation
and gene expression data from frozen human and chimpanzee
primary tissue samples. While we chose to work with tissues that
are relatively homogenous with respect to their cellular compo-
sition, we could not measure the precise composition or choose to
work with particular cell types, because the samples were frozen.
Similarly, we could not stage the tissues or control the
environment of the donor individuals because the samples were
collected post mortem. These are limitations shared by nearly all
comparative molecular studies of primary tissues from humans
and other apes (see [8,9] for more detailed discussions of the
limitations associated with studying gene regulation in primate
tissues).
The challenge is therefore to focus on patterns in the data that
should be robust with respect to the aspects of the study design that
could not be controlled. For example, it is reasonable to expect
that differences in environment, staging, and cellular composition
across samples will tend to increase variation of measurements
within, and especially between species. For that reason, our
analysis of conserved inter-tissue gene expression differences and
tissue-specific methylation patterns is likely to be conservative.
Indeed, because of our inability to minimize environmental
differences across the donor individuals, it is likely that we are
underestimating the proportion of conserved inter-tissue gene
expression differences and conserved T-DMRs.
In turn, when we focus on inter-species differences in DNA
methylation and gene expression levels, it is important to note that
our study design does not allow us to distinguish between
regulatory differences due to either heritable or environmental
effects. Studies in model organisms typically do so by controlling
the environments of all subjects, a restriction we cannot apply
when studying primate tissues. However, we have previously
shown that estimates of differences in gene regulation between
humans and chimpanzees based on six randomly sampled
individuals are stable [8,9]. Regardless of the underlying
mechanism, it is likely that the analysis of the data uncovered
mostly steady-state inter-species regulatory differences. Thus, even
if differences in environments underlie a subset of the observed
regulatory differences between humans and chimpanzees, our
previous work suggests that it is likely that, in most cases, we
capture the effects of general environmental differences between
the species, not just between the samples used.
DNA methylation and differences in gene expression
across tissues
We found a substantial degree of conservation of tissue-specific
methylated regions in human and chimpanzee. This observation is
not surprising given that previous studies found a marked
conservation of T-DMRs between human and mouse, which are
much more distantly related [26,41,43,44]. On the other hand,
7.0%, 21.6%, and 23.8% of the kidney, heart, and liver T-DMRs,
Gene Regulation by DNA Methylation in Primates
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methylated (in the relevant tissue) between humans and chimpan-
zees, while only 3.3%, 8.0%, and 11.8% of non-TDMRs in these
three tissues were differentially methylated between the two species
(P,10
210 for all pairwise comparisons).
The conservation of T-DMR profiles yet the generally faster
rate of inter-species change in promoter methylation at T-DMRs
compared to non-T-DMRs are intriguing. These observations are
difficult to explain by technical or uncontrolled aspects of the study
design, because it is unlikely that those confounding factors would
affect methylation at T-DMRs differently than at non-T-DMRs.
Instead, it is likely that the different patterns truly reflect a
functional difference between methylation at T-DMRs and at non-
T-DMR CpG sites (in the studied tissues).
Figure 4. Inter-species methylation and gene expression differences. (A) Scatter-plots of the p-values obtained by testing the null
hypothesis of no differences in gene expression levels between human and chimpanzee before (x-axis) and after (y-axis) regressing out methylation
levels. The solid purple lines correspond to a 1% FDR threshold. (B) Boxplots of the distributions, based on 1000 permutations, of the percentage of
genes for which the evidence for inter-species differences in gene expression levels is expected to be reduced following the correction for
methylation levels, by chance alone. Yellow points indicate the percentages seen in the actual data. (C) A representative example of the ZBTB80S
gene, which is associated with inter-species promoter methylation differences in the kidney. In the left and middle panels are the human and
chimpanzee methylation b-values and normalized gene expression levels, respectively. In the right panel are the normalized gene expression levels
for ZBTB80S, after correcting for the methylation b-values.
doi:10.1371/journal.pgen.1001316.g004
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levels upstream of genes are often inversely correlated with gene
expression levels [24,28,31], recent studies proposed that methyl-
ation of promoters may play only a relatively minor role in the
regulation of tissue-specific gene expression [34]. In particular,
Maunakea et al. [48] posited that methylation of gene body regions
(in regions that putatively serve as alternative promoters) might
have a greater influence on regulatory differences across tissues.
While we cannot use our data to ask about the relative importance
of different types and locations of epigenetic marks to tissue-
specific gene regulation, our observations strongly imply that any
such debate would benefit from further investigation into the
evolution of epigenetic profiles. Indeed, in addition to a faster rate
of evolutionary change of the methylation profiles in T-DMRs, we
found evidence for an enrichment of inverse correlations between
inter-tissue gene expression patterns and promoter methylation
profiles at genes associated with T-DMRs, but not when we
considered all genes (the latter observation is consistent with the
findings of Weber et al. [34] and Maunakea et al. [48]). Our
results, therefore, imply that tissue-specific promoter methylation
patterns may play especially important roles in regulating gene
expression. The data also suggest that altered methylation levels,
primarily at these sites, may underlie regulatory differences
between species.
DNA methylation and inter-species differences in gene
regulation
We estimated that as much as 12–18% (depending on the tissue)
of inter-species differences in gene expression levels might be
explained, at least in part, by changes in DNA methylation
patterns. It is important to note that this statement is based on the
proposed mechanism by which DNA methylation affects the rate
of transcription and overall levels of gene expression [28,31].
Though we did not perform experiments from which causality can
be directly deduced, a causal relationship between changes in
DNA methylation and gene regulation is strongly supported by
previous studies (e.g., [24,28,31]). When we only consider negative
correlations between methylation and gene expression levels to be
indicative of a putative causal relationship, 8–9% of inter-species
differences in gene expression levels might be explained by
corresponding changes in DNA methylation.
However, other mechanisms are also likely [34,43]. While DNA
methylation is typically considered a silencing mechanism, high
levels of methylation may be causally linked to increased gene
expression levels. For example, the methylation of a repressor site
could prevent the binding of repressor transcription factors, or
enhancer transcription factors could favor binding to a methylated
site rather than to the unmethylated site [49–51]. The observation
of a small enrichment of positive correlations between methylation
and expression when only T-DMRs are considered provides
additional support for these types of mechanisms. Thus, perhaps as
much as 12–18% of differences in gene expression levels between
humans and chimpanzees might be explained by inter-species
changes in DNA methylation.
Either way, our results suggest that DNA methylation
differences in promoter regions might account for, at most, a
modest proportion of inter-primate differences in gene expression
levels (we confirmed that our estimates do not rely on arbitrary
choices of specific statistical cutoffs; Tables S2 and S5). Many
inter-species differences in promoter methylation are not associ-
ated with gene expression differences between the species. One
explanation for that observation may simply be that these
methylation patterns are not regulatory or functional. An
alternative, more interesting possibility to consider, is that a subset
of genes whose regulation differed between species later acquired
modifications in nearby DNA methylation patterns to accommo-
date (or even partially counteract) the original expression level
changes.
Since we assayed methylation using a pre-designed microarray,
changes in DNA methylation in un-assayed genomic regions might
explain additional regulatory differences between the species. In
particular, while our assay focused on methylation at promoter
regions, it has been recently shown that as a class, gene-body
methylation profiles might explain a larger proportion of variation
in gene expression levels than methylation profiles at currently
annotated promoters [26,48]. With the advent of new sequencing
technologies, it will soon be feasible to extend our comparative
approach to characterize genome-wide patterns of methylation.
In summary, we have taken some of the first steps towards
characterizing variation in one mechanism that affects gene
expression differences between closely related primate species
[16,17]. In a broader context, DNA methylation is just one of
many mechanisms that have been posited to regulate gene ex-
pression levels [28,31,52]. In that sense, our study is a step towards
the ultimate goal of understanding the relative importance of
changes in different regulatory mechanisms to human evolution.
Our observations indicate that at least 82% of gene expression
differences between humans and chimpanzees (in the three studied
tissues and specific promoter CpG sites examined) are not likely to
be explained by differences in promoter DNA methylation.
Methods
DNA methylation data
We collected methylation data from the same human and
chimpanzee liver, kidney, and heart tissue samples used in
Blekhman et al. 2008 [8] (Figure S1; see Table S6 for details on
the samples). DNA was extracted from each sample (6 human and
6 chimpanzee samples from each of the three tissues) in two
independent technical replicates using the QIAamp DNA Mini
Kit (Qiagen) (with the exception of chimpanzee sample CK2, for
which DNA was only available for one replicate – see Table S4).
The methylation profile of each sample was assayed using the
Illumina HumanMethylation27 DNA Analysis BeadChip, which
assays methylation at 27,578 CpG sites. Methylation array data
are deposited to the NCBI GEO database under the accession
number GSE26033 (http://www.ncbi.nlm.nih.gov/projects/geo/
query/acc.cgi?acc=GSE26033).
To facilitate an unbiased comparison of methylation and gene
expression levels in the human and chimpanzee samples, we first
mapped the 27,578 50-bp Illumina probes to the human genome
sequence (hg18) using BLAT [53] and MAQ [54]. We retained
only the 26,690 probes that unambiguously mapped to a single
location in the human genome with a maximum of two
mismatches. These probes were then associated with the nearest
gene using Ensembl gene annotation, and we retained only the
subset of probes associated with genes that were represented on
the multi-species gene expression microarray used by Blekhman et
al. 2008 [8]. This resulted in the retention of 19,849 probes,
associated with 11,059 genes. Finally, since the Illumina array was
designed based on human genomic sequence, we limited our
analysis to probes that were a perfect sequence match to a single
location in the chimpanzee genome, by mapping the remaining
19,849 probes to the chimpanzee genome (panTro2) using BLAT
[53] and MAQ [54]. We retained 10,575 probes that mapped
uniquely to the chimpanzee genome with no sequence mismatch-
es. This step ensures that our relative methylation measurements
are not biased due to the effect of sequence mismatches on
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associated with 7,723 genes, which are present on every
chromosome in the genome except for the Y-chromosome (Figure
S10). The majority (97%) of retained probes are located within
2 kb of an annotated transcription start site of the associated gene
(Figure S11). We note that a similar screen for probes that were a
perfect match to the genomes of human, chimpanzee, and rhesus
macaque resulted in the retention of only 1,944 probes (associated
with 1,715 genes). For that reason, we limited our current study to
a comparison between human and chimpanzee samples.
All samples were hybridized to the Illumina HumanMethyla-
tion27 DNA Analysis BeadChip at the Southern California
Genotyping Consortium facility following standard manufacturer’s
instructions. Basic quality checks were performed using Illumina’s
BeadStudio software. Of the 10,575 probes we considered as the
final dataset, 299 had missing data for one or more individuals and
were discarded in all subsequent analyses. This resulted in 9,911
autosomal probes (corresponding to 7,291 genes) and 365 probes
on the X-chromosome (corresponding to 266 genes). Since the
probes map to distinct CpG island regions, which can affect
downstream gene expression independently, we treated methyla-
tion levels from each CpG probe as distinct data points in all
subsequent analyses. We further classified each probe as being
located confidently within a CpG island region or outside of a
strict CpG island region using the CpG Islands track information
downloaded from UCSC [47].
For each sample, the methylation status at a probed location
was summarized as:
b~
M
MzUz100
where M and U denote the signal emitted from the beads assaying
the methylated and unmethylated versions at each site, respec-
tively. Due to the number of samples being interrogated, it was
necessary to hybridize the samples in two balanced batches. We
observed a small difference in the mean b-value between batches,
and corrected for this difference by standardizing the means across
batches. After this correction, there was no further evidence for a
batch effect.
To further assess the quality of the data, we calculated pairwise
correlations between the b-values for all hybridized samples (Figure
S2). As expected, technical replicates (which were independent
DNA extractions) were the most highly correlated (36 comparisons;
median r=0.99), followed by samples from the same tissue and
species (396 comparisons; median r=0.98), samples from the same
tissue across species (432 comparisons; median r=0.97), samples
from different tissues from the same species (864 comparisons;
median r=0.95), and samples from different tissues and different
species (864 comparisons; median r=0.93).
To look for evidence of imprinting in both humans and
chimpanzees, we focused on a set of 27 genes (associated with 90
methylation probes) known to be imprinted based on the
Imprinted Gene Catalog (IGC) at http://igc.otago.ac.nz/. To
assess whether the patterns of DNA methylation at these imprinted
genes were likely to occur by chance, we compared the observed
proportion of hemi-methylated sites (defined as 0.3,b,0.7) to the
distribution obtained by analyzing methylation patterns in 1000
randomly chosen sets of 90 methylation probes, associated with an
average of 27 genes (range 26–28).
Gene expression data
Measurements of gene expression levels for all samples in our
study were previously described by Blekhman et al. (2008) [8].
These data are available at the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/geo/) under series acces-
sion number GSE11560. In that study, a multi-species microarray
was used to estimate gene expression levels in cDNA samples from
humans, chimpanzees, and rhesus macaques. The multi-species
array includes orthologous probes for 18,109 genes, thus
facilitating comparisons of gene expression levels between species
without the confounding effects of sequence mismatches on
hybridization intensities [8]. Since our current study focused only
on the human and chimpanzee gene expression data, we re-
normalized the expression data using only the human and
chimpanzee probes on the array, using the same modified quantile
normalization approach described in Blekhman et al. (2008) [8].
All further analyses used these re-normalized gene expression
estimates. When examining the relationships between gene
expression and methylation levels, we limited our analyses to
genes that were either expressed in at least one tissue (for inter-
tissue comparisons within a species) or expressed in at least one
species (for the inter-species comparisons within a tissue), using a
conservative threshold for defining expression, based on the entire
distribution of expression values (normalized expression value of 8;
see Figure S14 in Blekhman et al. (2008) [8]).
Statistical analysis
All statistical analyses were performed using the R statistical
framework (http://www.r-project.org).
Identifying tissue-differentially methylated regions
(T-DMRs)
To identify T-DMRs, we modeled the methylation level of each
CpG site separately within both humans and chimpanzees using a
linear mixed-effects model. Specifically, for each of the 9,913
probes (associated with 7,291 genes) located on the autosomal
chromosomes, if yijk represents the b value for technical replicate k
(k=1 or 2), for individual j( j=1,…,6), from tissue i (i=heart, liver,
or kidney), we assume that:
yijk*N(mijk,s2) ð1Þ
where:
mijk ~ai zrij i~ H,L,K ½ 
Here, ai represents the mean methylation value at a given site in
tissue i. To account for correlation between samples of the same
tissue from different individuals, a random effect, rij, which follows
a N(0,s
2
rand) distribution, is also included in the model.
To determine whether a CpG site was likely to fall within a T-
DMR, we assessed how well the model (1) fitted the data under
various parameterizations of mijk. The three types of parameter-
izations considered are:
Ho : aH~aL~aK
H1 : aH=aL~aK; aH~aL=aK; aH~aK=aL
H2 : aH=aL=aK
In the simplest model (H0), the region’s methylation value is
assumed to be constant across all three tissues, while in the second
alternative (H2) the methylation value is allowed to differ between
all three tissues. The first alternative (H1) models the situation
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two non-target tissues but differs in the target tissue. All models are
fitted using a restricted maximum likelihood (REML) framework,
and the maximum likelihoods were calculated.
In this study, we are interested in identifying sites whose
methylation levels are best modeled by H1. To find such sites, we
first used a likelihood-ratio test statistic (with one degree of
freedom) to exclude sites where H2 provides a better fit to the data
than H1 (specifically, if the likelihood-ratio p-value was less than
0.05, we removed these sites from the analysis). H2 provides a
better fit for 1220 and 886 (in humans and chimpanzees,
respectively) of the total 9911 autosomal CpG sites. For the
remaining positions, we examined whether there was significant
evidence to reject H0 in favor of H1 using a likelihood-ratio test
statistic (which we compared to a x
2 distribution with 1 degree of
freedom). We corrected for multiple testing using the FDR
approach of Storey and Tibshirani [55].
Gene ontology analysis for T-DMRs
We used GeneTrail (http://genetrail.bioinf.uni-sb.de) [56] to
test for enrichments of functional annotations among different
classes of T-DMRs. In all tests, we used a background set of genes
that were present in our study and classified as expressed in at least
one tissue (conditional on a normalized expression value of 8). The
tests were performed using all GO categories and KEGG
pathways. We calculated p-values using a Hyper-geometric
distribution and report false discovery rates for each p-value.
A joint analysis of methylation and gene expression
levels
To examine whether changes in gene expression levels between
humans and chimpanzees (within each tissue) can be explained by
inter-species differences in methylation levels, we extended the
linear mixed-effects model framework described in Blekhman et al.
(2008) [8] to include methylation as a covariate. However, since
we have to correct the multi-species array data for probe-effects
[8], it is difficult to interpret the methylation coefficient when it is
added directly to the model, since it is confounded with the probe
effects. Consequently, we used an alternative approach in which
we used regression to correct for the methylation effect.
Specifically, for each gene-tissue combination, we tested for
differences in expression level between human and chimpanzee
after regressing out the following effects:
1. Expression microarray probe effects only
2. Expression microarray probe effects and CpG-specific meth-
ylation levels
To do this, we used a fully parameterized model where gene
expression probe effects, CpG-probe methylation values, and
species effects were explanatory variables. Additionally, a random
effect was used to account for variability between biological
replicates. Specifically, if ysroi denotes the normalized log2 intensity
expression value for individual i (i=1,…,6), from species s
(s=human or chimpanzee) measure at probe r (r=1,…,7), which
is derived from species o, we assume that:
ysroi*N(hsroi,s2)
where:
hsroi~mszprozksrozcsizbsi
Here, ms denotes the species effect, pro is a fixed-effect representing
the probe effect for each individual probe within a probe-set and
the composition effect of species-specific orthologous probes, and
ksro is a fixed-effect representing the attenuation of hybridization
intensities due to sequence mismatches between species of RNA
and a species-specific derived probe, which are different for each
individual probe within a probe set (see [8] for more details).
Additionally, csi is a random effect (following a N(0,s
2
rand)
distribution) and bsi denotes the b value for the methylation
probe of interest for individual i from species s. Upon fitting this
model, using the lmer package within the R statistical framework,
estimates of the parameters and the residuals were obtained. To
obtain corrected measures of expression for each individual from
each species, ^ y ysi when probe and methylation effects are regressed
out (scenario 2), we defined ^ y ysi~mszcsi. When we only regressed
out probe effects (scenario 1), the corrected values are defined as
^ y ysi~mszcsizbsi. In both of these scenarios, once the corrected
data were obtained, we tested for differences in gene expression
levels as follows. If, for each tissue-gene combination, xsik denotes
the (corrected) level of expression for replicate k of individual i
from species s, we modeled these data as follows:
xsik*N(msik,s2)
where:
msik~aszrsi
Here, as is a species effect, and rsi is a random individual effect.
Subsequently, to test for inter-species differences in expression
levels, we compare the following hypotheses:
H0 : ahuman~achimp
H1 : ahuman=achimp
Here, the null model assumes equal expression level between the
two species, and the alternative assumes different expression levels.
Evidence against the null model was determined using a
likelihood-ratio test statistic (compared against a chi-squared
distribution with one degree of freedom). By performing this
analysis independently for each CpG-gene combination in all
tissues, we obtained a p-value indicating the strength of the
evidence against the null hypothesis, before (under scenario 1
above) and after (under scenario 2 above) accounting for the
region’s DNA methylation status. By comparing these p-values, we
were able to identify genes within each tissue where the difference
in expression level between human and chimpanzee was likely
explained by inter-species differences in DNA methylation.
To assess the statistical significance of our observations, we
permuted the methylation values for a given gene across all
individuals (maintaining replicate correlations, but allowing labels
to permute across species classifications). Subsequently, we
repeated the analysis described above to obtain an expected
distribution of discrepancies between the methylation-corrected
and uncorrected data. We performed 1000 permutations and p-
values were calculated based on the number of times we observed
as many or more discrepancies in the permuted compared to the
real data.
In order to estimate the proportion of genes for which
methylation differences might underlie gene expression differenc-
es, we treated the medians of the permutation distributions from
each tissue as background levels. For each tissue, we then
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genes with reduced evidence for inter-species differences in gene
expression levels, once methylation was taken into account.
Supporting Information
Figure S1 An illustration of the methylation profiling study
design.
Found at: doi:10.1371/journal.pgen.1001316.s001 (1.48 MB TIF)
Figure S2 Boxplots of distributions of pairwise Pearson
correlations between methylation array data, by category.
Found at: doi:10.1371/journal.pgen.1001316.s002 (0.82 MB TIF)
Figure S3 Boxplots of the distributions of the proportion of
divergent nucleotides between human and chimpanzee in 500bp
windows around each 50bp probe. The probes are divided into
those that are a perfect and unique match to both the human and
chimpanzee genomes (left) and those that are a perfect and unique
match to the human genome but not the chimpanzee genome
(right).
Found at: doi:10.1371/journal.pgen.1001316.s003 (0.15 MB TIF)
Figure S4 Distributions of methylation values (x-axis) within
each species-tissue type, for CpG islands associated with genes
whose expression levels rank at different quartiles (colored lines).
Found at: doi:10.1371/journal.pgen.1001316.s004 (0.89 MB TIF)
Figure S5 Principal components analysis of the expression
profiles. Considering the 7,291 autosomal genes from all samples
(PC1 and PC2 are plotted on the x-axis and y-axis, respectively).
Found at: doi:10.1371/journal.pgen.1001316.s005 (0.11 MB TIF)
Figure S6 Density (y-axis) histograms of distributions of Pearson
correlations (x-axis) between methylation and gene expression
levels across tissues in human (solid lines) and chimpanzee (broken
lines) for all genes expressed in at least one tissue (black; plots are
identical in the three panels), genes associated with a T-DMR in
only one species (blue; data from T-DMRs in liver, kidney, or
heart are plotted separately in each panel), and genes associated
with a conserved T-DMRs (red; separated by tissue).
Found at: doi:10.1371/journal.pgen.1001316.s006 (0.49 MB TIF)
Figure S7 Boxplots of distributions of Pearson correlations (y-
axis) between methylation and gene expression levels across tissues
in human (bold lines) and chimpanzee (non-bold lines) for all genes
expressed in at least one tissue (black), genes associated with a T-
DMR in only one species (blue), and genes associated with
conserved T-DMRs (red). Each category is further divided into
CpG sites that are located within CpG islands (‘‘In’’) or outside of
a CpG island (‘‘Out’’). The P-values for a significant difference
between the ‘‘inside’’ and ‘‘outside’’ distributions for each category
are located below the x-axis.
Found at: doi:10.1371/journal.pgen.1001316.s007 (0.18 MB TIF)
Figure S8 Boxplots of the distributions, based on 1,000
permutations, of the percentage of genes for which the evidence
for inter-species differences in gene expression levels is expected to
increase following the correction for methylation levels, by chance
alone. Yellow points indicate the percentages seen in the actual
data.
Found at: doi:10.1371/journal.pgen.1001316.s008 (0.07 MB TIF)
Figure S9 Barplots of the percentages of genes in each tissue for
which the evidence for inter-species differences in gene expression
levels is reduced following the correction for methylation levels.
Each tissue is further divided into CpG sites that are located with-
in CpG islands (‘‘In’’) or outside of a CpG island (‘‘Out’’). The
P-values for a significant difference (compared to expectations
from a chi-squared distribution) between the ‘‘inside’’ and
‘‘outside’’ percentages for each category are located above the
barplots.
Found at: doi:10.1371/journal.pgen.1001316.s009 (0.16 MB TIF)
Figure S10 Histogram of the number of CpG site probes (y-axis)
on each chromosome, except the Y-chromosome (x-axis).
Found at: doi:10.1371/journal.pgen.1001316.s010 (0.23 MB TIF)
Figure S11 Frequency (y-axis) histogram of the distances from
CpG sites assayed in our study to the transcription start sites (TSS)
of the nearest annotated genes. The inset is an expanded view of
frequency (y-axis) histogram near the 2kb around the TSS, where
97% of the probes are located.
Found at: doi:10.1371/journal.pgen.1001316.s011 (0.22 MB TIF)
Table S1 Summary of the data for all CpG probes.
Found at: doi:10.1371/journal.pgen.1001316.s012 (6.64 MB
XLS)
Table S2 Percentages of negative correlation between methyl-
ation and expression levels in T-DMRs across a range of statistical
cutoffs used to classify T-DMRs.
Found at: doi:10.1371/journal.pgen.1001316.s013 (0.03 MB
XLS)
Table S3 Gene ontology categories that are the most signifi-
cantly enriched or depleted GO annotations among genes that are
classified as T-DMRs in either species (P,0.01). For this analysis,
we used a background of all genes assayed in our study that are
expressed in at least one tissue. GO tables for T-DMRs specific to
each tissue are located on individual sheets.
Found at: doi:10.1371/journal.pgen.1001316.s014 (0.06 MB
XLS)
Table S4 Gene ontology categories that are the most signifi-
cantly enriched or depleted GO annotations among genes that are
classified as T-DMRs in both species (shared T-DMRs) (P,0.001).
For this analysis, we used a background of all genes assayed in our
study that are expressed in at least one tissue. GO tables for T-
DMRs specific to each tissue are located on individual sheets.
Found at: doi:10.1371/journal.pgen.1001316.s015 (0.03 MB
XLS)
Table S5 Estimates of the percentage of genes for which
methylation differences could underlie inter-species expression
differences, across a range of significance thresholds.
Found at: doi:10.1371/journal.pgen.1001316.s016 (0.03 MB
XLS)
Table S6 Information on the 36 samples used in this study.
Found at: doi:10.1371/journal.pgen.1001316.s017 (0.09 MB
DOC)
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